A Nurse-Led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease.
Introduction
Chronic obstructive pulmonary disease (COPD) represents a global health burden and will move from 12 th place to be the 5 th largest cause of disability adjusted life years lost by 2020 1 . In the UK, 30,000 deaths per year are attributed to COPD, over 5% of all deaths 2 , and up to one in eight emergency hospital admissions may be due to COPD 3 . Much of the morbidity and mortality related to the condition results from exacerbations of the disease and frequent exacerbations are associated with more rapid decline in lung function 4 . These exacerbations are much feared by patients who dislike their impact upon everyday life and fear being housebound, bedridden or hospitalised 5, 6 . Previous research has focussed on optimal therapeutic strategies for both the prevention 7, 8, 9, 10 and treatment of acute exacerbations 11 and also on the effectiveness of care interventions such as "hospital at home" and early discharge schemes for those having acute exacerbations of COPD 12, 13 . A systematic review of the effectiveness of innovations in nurse-led management has concluded that there is little evidence to date to support such interventions, but the authors conclude that the data is too sparse to be certain and none of the studies extended beyond a duration of 12 months 14 . There is a similar lack of evidence to show whether self management education alters outcomes in COPD 15 .
We have undertaken a randomised controlled trial to determine the effects of a nurse led intermediate care programme in the management of patients who have been hospitalised with an acute exacerbation of COPD. The care package incorporated initial pulmonary rehabilitation followed by an emphasis on self management education and nurse follow up for two years.
Methods
A list of patients who had been admitted to Charing Cross and Hammersmith Hospitals between 1st January 2000 and 31st August 2004 with the main reason for admission being coded on discharge as having been due to an acute exacerbation of COPD was obtained from the hospital database. The clinical notes of these patients were reviewed by the investigators using a proforma. If thought to represent a suitable patient, the casenotes were discussed and where necessary further information obtained. Exclusion criteria included significant co-morbidity such as severe heart disease or cancer, or any condition that would preclude participation in the physical therapy component of a pulmonary rehabilitation programme. None of the patients had previously undertaken a pulmonary rehabilitation programme. Those patients thought to be suitable were sent a letter inviting them to participate in the study and those who responded were invited for initial assessment, and if still suitable and agreeable, randomised to the intervention or usual care groups.
The study intervention involved all patients initially participating in a hospital based pulmonary rehabilitation programme consisting of two attendances per week for four weeks. During this the patients received general education about their disease and its treatment (one hour per session) and underwent an individualised physical training programme (one hour per session). Following completion of the pulmonary rehabilitation programme, the patients received a baseline home visit by a specialist respiratory nurse and during this first visit, the patients were given a personalised written COPD action plan (a copy of which is shown in Appendix A). This contained both lifestyle advice and advice about their usual medication and gave specific advice about when the patient should start a course of antibiotics and when they should start a course of steroid tablets. The general practitioners of these patients were requested to provide for the patient reserve supplies of these medications.
Subsequently those in the intervention group had monthly telephone calls from the respiratory nurses and a home visit every three months. During each interview and visit, the nurses undertook a structured approach to history taking and during home visits measured pulse and respiratory rate, oxygen saturation and end-tidal carbon monoxide. Spirometry was performed at baseline and after 12 and 24 months. During both telephone and home visits they reinforced advice regarding treatments, smoking cessation if relevant, the need to continue their exercise therapy and discussed and reinforced the self management education which had been given and offered encouragement for successful self treatment. The patients were also given written advice about the treatment of chronic obstructive pulmonary disease which they were asked to show to their doctor if they underwent any unscheduled healthcare.
Patients in the control group received usual care from their primary care physician, or secondary care and/or the respiratory nursing service as appropriate. No attempt was made to influence this care. Patients in both the control and intervention group had their use of healthcare monitored by monthly telephone self report verified by confirmation of the general practice and hospital records. General practice records alone were not used because they do not always contain a record of hospital admissions and it is not always possible to tell which consultation within primary care was scheduled and which was unscheduled. Corroboration of patient self reported GP consultations was undertaken by the GPs themselves from their records. Corroboration of patient self reported hospital admissions was undertaken by the respiratory research nurses against local hospital records. A copy of the death certificate was requested for all patients who died.
Quality of life was assessed using the Chronic Respiratory Questionnaire (CRQ) 16, 17 at baseline and three further times during the subsequent two years.
The study was approved by the Riverside Research Ethics Committee.
Statistical Analysis
The primary endpoint for our trial was to be hospital readmission rate with secondary outcomes being unscheduled consultations with general practitioner and quality of life. Retrospective review of previous local hospital admission rates suggested that over a two year period 579 patients might accrue a total of 1180 admissions (mean 2.04 admissions per patient). We calculated that we would need a study of 88 patients to have an 80% chance of detecting a difference (95% readmission in usual care versus 75% in the intervention group), using a two sided alpha = 0.05. All statistical analysis was carried out using the software program SPSS (Version 12.0). For all analyses Chi-square tests, Mann Whitney, independent or paired t-tests were used.
Results
There were 2,305 admissions to Hammersmith Hospitals NHS Trust between the 1st January 2000 and 31st August 2004. Many of those were multiple admissions and the total number of patients admitted with an acute exacerbation of COPD in that period was 1,247. Five hundred and seven of these patients had died at the time we began recruiting to this study and of the 740 who were alive, 166 lived outside our area and were not therefore able to attend the pulmonary rehabilitation programme if randomised to intervention. This left 574 patients who were assessed. Two hundred and seventy-seven of these were thought to be unsuitable for the reasons shown in Table 1 . Table 1 Reasons for patients being regarded as unsuitable to be included in the trial n=277
Alternative diagnosis, no evidence of COPD -122 (44.1% ) These were mainly because perusal of the notes gave clear evidence of another major pulmonary condition, such as asthma, diffuse parenchymal lung disease or bronchiectasis.
Psychosocial problems and significant cognitive impairment -68 (28.5%) (e.g. dementia, blindness, alcohol abuse, psychiatric illness, homelessness or in prison).
Severe limiting co-morbidity involving other major organ systems -50 (18.1%) (mainly cardiac but also cancer and alcohol-related liver disease etc.)
Factors limiting mobility and locomotion -37 (13.3%) (housebound, wheelchair-bound, previous CVA, severe arthritis).
Of the 297 patients who were suitable for inclusion in the trial, 120 (40.4%) responded that they did not wish to take part in the trial, 55 (18.5%) did not reply and 122 (41%) patients were suitable and recruited and were randomised by the use of random numbers to intervention or control groups. This data is summarised in the Consort diagram in Figure 1 . Demographic data and details of severity, treatment, unscheduled use of healthcare and quality of life for all patients at baseline and at the end of Year 2 is shown in Table 2 . From these tables it will be seen that at baseline both control and intervention groups were well matched for age, gender, severity of disease, previous hospitalisation rate, breathlessness scores, weight, smoking habits and use of home oxygen. Both groups had similar numbers of initial and persisting smokers and the breathlessness scores worsened during the course of the study in both groups. Lung function appeared to decline to a greater degree in the control group than in the intervention group, but this difference was not statistically significant. At baseline similar proportions of patients were on long acting beta agonist bronchodilators and anti-cholinergic agents and the majority of patients in both the intervention group and control group were taking inhaled steroids at entry to the trial. At the end of the trial patients in the intervention group were statistically more likely to be on a long acting inhaled beta agonist or a short or long acting anti-cholinergic agent in the intervention group, compared with the control group.
At the beginning of the trial, 5% of the intervention group and 11.5% of the control group had a reserve supply of antibiotics; the same figures for steroid tablets were 5% and 7% respectively. After the intervention, over 95% had both type of reserve treatments available, compared with the control group, where 17% had antibiotics available at the end of one year and 25% of them had it at the end of two years. Sixteen percent of the control group had a reserve supply of steroid tablets at the end of two years. There were no differences in exacerbation rates between the two groups (an exacerbation being defined as unscheduled need for healthcare, or need for steroid tablets, or antibiotics for a worsening of their COPD), nor was there a difference in the total number of exacerbations per group over the two year period. There was also no difference in the total number of hospital admissions, nor in the number of patients having an admission to hospital during the two year period. Because this could have been influenced by differences in the death rates, this was also analysed as days alive and out of hospital in the two groups, but there was no statistically significant difference. Self management of exacerbations was however significantly different and patients in the intervention group were more likely to have exacerbations treated with oral steroids alone or oral steroids and antibiotics than the control group, who were more likely to be treated with antibiotics alone. The initiator of treatment for exacerbations was statistically more likely to be the patient themselves in the intervention group and the GP in the control group.
Twelve patients in the control group died during the two year period, eight as a result of COPD, compared with six patients dying in the intervention group of which one died from COPD. The number dying from COPD in the control group is significantly higher both as a proportion of the total deaths and as a proportion of all patients in the trial compared to those in the intervention group. The non-COPD deaths included four deaths due to pneumonia (three in the control group and one in the intervention group), one due to metastatic lung cancer, one due to cerebral haemorrhage, two due to coronary artery disease, and one due to septic shock. All but two patients died in hospital. Stated cause of death was confirmed by acquisition of copies of the death certificates in all but one case. One patient died on a cruise ship off the coast of West Africa and death was reported by relatives to have been due to a worsening of their lung condition over a several day period following exposure to adverse environmental conditions. When the numbers in the intervention and the control groups are adjusted to reflect the numbers still alive, it can be seen that at two years, 55 of the 61 patients in the intervention group were still alive, and these patients had had a total of 171 unscheduled contacts with their GP. In the control group, 49 of the 61 patients were still alive, and they had had 280 contacts with their GP. The number needed to treat, therefore, equals 0.558. That is to say, for every one COPD patient receiving self management education, there was 1.79 less unscheduled contacts with the GP. The health economic costs of the pulmonary rehabilitation programme are shown in Table 4 , and suggest that the costs of the intervention are only very slightly greater per patient than the savings on unscheduled primary healthcare (£153 compared to £142).
Within the CRQ there was a statistical and clinical significant worsening in the mean dyspnoea score in both the intervention and control groups from baseline to end of Year 2 and the mean mastery score improved in the intervention group but this change was not clinically significant.
To ensure that any differences did not reflect differences in routine healthcare received, data in Table  3 shows that equal numbers of patients received primary care alone in both the intervention and control groups but some in the control group also received care from the local respiratory nursing service. They may have been offered care which contained some similarities to that offered by the research respiratory nurses. 
Discussion
The proportion of patients who had been admitted to hospital with an exacerbation of COPD who were eligible for and consented to take part in this trial was lower than anticipated. This was because of both polymorbidity and non consent and the latter was due more to the intervention including pulmonary rehabilitation than it was due to it being a research trial 18 . As a result recruitment was lower than expected but neither the total number of readmissions nor the number of patients having an admission during the 2-year follow up period differed between the intervention and control groups. This result is thus consistent with a previous review 14 but extends our knowledge to show that the same applies if the intervention continues for 2 years. The secondary outcome of rate of unscheduled GP consultations was significantly less in the intervention group.
It thus looks as though the self management education part of the intervention, given in group format during the pulmonary rehabilitation programme and individually by the nurse subsequently, led to intervention patients being more likely to have received supplies of antibiotics and steroids and more likely to start these themselves to treat an exacerbation than the control group.
Unexpectedly we showed a significant reduction in deaths due to COPD in the intervention group. We acknowledge the difficulties around the accuracy of death certificates. However this reduction in death rate could be explained by a reduction in the severity of exacerbations as a result of self treatment with antibiotics and steroid tablets and it is probable that the ready availability of reserve medications leads to their prompter use, and earlier treatment of exacerbations has been shown to be associated with improved outcomes 19 . A less likely explanation for a reduced death rate would be differences in routine inhaler therapy in the intervention group compared with the control group. Whilst controversial, there have been suggestions that the use of inhaled steroids [20] [21] [22] [23] [24] might be associated with a reduction in mortality. However, essentially all patients in both the intervention and control arms in our trial were on inhaled steroids, but there were differences in the use of anticholinergic agents and long acting beta agonists in our intervention arm and this may have contributed to increased survival 8, 9, 24 . However most of those who died were also on these medications. The likelihood that the reduction in mortality instead reflected prompt self treatment would be consistent with review of eleven randomised controlled trials comparing antibiotics with placebo for acute worsening of COPD, which showed that regardless of antibiotic used, antibiotic therapy significantly reduced mortality 25 . Such a reduction in mortality as a result of steroid tablet use has not been demonstrated 26 . Why we demonstrated a significant reduction in unscheduled need for primary healthcare and a reduction in mortality, but no reduction in hospital admission rates is less clear. Self administration of antibiotics (and steroid tablets) may have reduced the severity of exacerbations sufficiently to reduce mortality without influencing the need or otherwise for admission to hospital which is in any way likely to be influenced by social factors such as isolation, depression and available support in the home.
There are clearly still many unknowns with regards to what constitutes optimal care for those with COPD. We included pulmonary rehabilitation within our intermediate care package because it contains elements of exercise therapy, group support and group education and has been shown to beneficially affect outcomes such as quality of life, exercise ability, and breathlessness scores. It has not however been shown conclusively to affect hospitalisation rate, mortality or primary care consultation rates 27 . The improvements in the latter two outcomes in our study are therefore unlikely to reflect incorporation of pulmonary rehabilitation within the intervention package. Regular follow up by nurses in this study has again failed to demonstrate a benefit in terms of reduction in hospital admission rates and this result is almost identical to a shorter study from this hospital 20 years ago 28 However we have demonstrated that an intervention which includes group advice regarding selfmanagement education, followed by the issuing to each patient of a personalised action plan leads to an alteration in self-management behaviour and reduced need for unscheduled primary care. Previously the case for self management education in COPD was not proven 15 . Studies reported subsequent to that review, and subsequent to us starting this study, have shown conflicting results. One group 29 showed no differences in Quality of Life Scores or walking distance and no reduction in exacerbation rate following self-management education, whilst another demonstrated significant reduction in hospital admissions, emergency department visits and physicians visits 30 . In the latter study however, and indeed in our own, it is difficult to be certain which of several parts of a complex package achieved which benefit. The relationship between possession of antibiotics and oral steroids, their self-administration and the reduced need for unscheduled primary care in our study does appear to be causally related. One explanation for differences in previous studies may lie in the way in which the personalised self-management advice was given. In asthma, where there is overwhelming evidence in favour of self-management education 31, 32 , written action plans are a key component. In the systematic review of self-management in COPD 15 only two studies involved patients receiving a written action plan and study of the action plans used in those two studies shows that one was a typical asthma action plan 33 and did not for example include any advice to the patient about antibiotics. The other study 34 did include an action plan which included advice as to when to start antibiotics and this did show an alteration in patient usage of antibiotics and steroids but the study was not powered to show a change in outcomes. A subsequent Cochrane review 35 has suggested that use of action plans can alter self management behaviour in those with COPD but did not lead to any hard outcomes. Our study does show that self management education can be associated with change in patient behaviour and a reduction in the need for urgent primary care, and this plus follow up by nurses and possibly optimisation of inhaled therapy can be associated with reduced mortality due to COPD.
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